Sartorius stock: UBS keeps EUR 300 target for Sartorius stock

Published on 10/21/2026 at 17:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results are due October 22, 2026. Sartorius stock costs EUR 261.60 on October 21, 2026 at 5:30 p.m. CEST, plus 0.15 percent versus the Xetra close.

UBS target and reporting date

UBS kept its Buy rating and EUR 300.00 target for Sartorius on October 14, 2026.
Sartorius expects fiscal 2026 sales revenue growth of 5 to 9 percent and an underlying EBITDA margin above 30.00 percent.
Sartorius stock costs EUR 261.60 at Lang & Schwarz on October 21, 2026 at 5:30 p.m. CEST, 0.15 percent above the Xetra close of October 21, 2026.

Fotorealistische Bioreaktor-Anlage in Reinraumhalle mit Edelstahltanks und Technikern — Sartorius AG (Vz.) DE0006292006 zeigt fotorealistisch eine sterile Bioreaktor-Anlage mit Technikern in weißer Reinraum-Schutzkleidung, Illustration mit AI erstellt.

UBS kept its Buy rating and EUR 300.00 price target for Sartorius on October 14, 2026, ahead of the company results due October 22, according to FinanzNachrichten. The target is 14.68 percent above the EUR 261.60 price at Lang & Schwarz on October 21, 2026 at 5:30 p.m. CEST, while the stock was 0.15 percent above the Xetra close of EUR 261.20 on October 21, 2026.

UBS keeps results in view

The UBS note placed the focus on Sartorius's underlying growth path and cited tariff-related factors as a consideration. Its EUR 300.00 target is unchanged, giving the analyst view a defined distance from the German quotation rather than a fresh target increase.

The next company date is October 22, 2026, when Sartorius is scheduled to publish its third-quarter results and hold its 9M 2026 results conference call at 1:00 p.m. CEST, according to the Sartorius investor-relations page.

What guides the next report

For fiscal 2026, Sartorius guides to sales revenue growth of 5 to 9 percent in constant currencies and an underlying EBITDA margin above 30.00 percent. The company reported an underlying EBITDA margin of 29.70 percent for fiscal 2025, so the current objective implies a margin level above the prior-year figure.

Price position and valuation

The stock's 52-week range is EUR 198.50 to EUR 272.50 as of October 21, 2026. The EUR 261.60 quotation therefore stands EUR 10.90 below the high, while the market capitalization is EUR 16.6 billion. Sartorius trades at a price-to-earnings ratio of 91.91 on the available quotation reference.

Dates and investor context

The October 22 reporting date is the immediate event for the stock. The figures to watch are revenue growth, the underlying EBITDA margin and management commentary on tariffs, because UBS identified those factors alongside the long-term growth path.

Stock position after the Xetra close

At EUR 261.60, the Lang & Schwarz price was EUR 0.40 above the Xetra close of EUR 261.20 on October 21, 2026. The small daily difference leaves the analyst target and the scheduled results date as the clearest near-term reference points.

The further course of trading is shown by the continuously updated real-time quote of Sartorius stock.